Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Inflammatory Diseases
 More »

  • AbbVie Expands Galapagos Collaboration to Include Crohn's Disease
    GLPG0634 is one of five Galapagos pipeline molecules being studied for inflammatory ... AbbVie's pipeline includes mid- to late-stage clinical programs for diseases that include ...
    5-17-2013
  • FDA OKs Novartis' Drug for Childhood Arthritis
    conditions. "We are committed to studying Ilaris in other IL-1 beta-mediated inflammatory diseases, including several rare diseases for which treatment options do not currently ...
    5-10-2013
  • Biomarkers Take Center Stage
    ... the Erenna system can provide insights toward improving the clinical utility of biomarkers and accelerating the development of novel therapies for treating inflammatory diseases. ...
    5-1-2013
  • AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement
    Earlier this month , BIND announced a $210 million deal it made with Pfizer to develop and commercialize Accurins, which have shown effectiveness against inflammatory diseases, ...
    4-22-2013
  • BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal
    against RNA targets, both mRNA and microRNA, for a range of diseases including infectious and inflammatory diseases, cardiometabolic disorders, cancer, and rare genetic disorders. ...
    4-16-2013
  • Poland Invests in Biotech Infrastructure
    ... (Nystatin A1 and Amphotericin B), the golden standard treatments for these diseases. ... looking for marine extracts that have anti-inflammatory and immune modulation activity. ...
    4-15-2013
  • Yale Wins $10 Million Grant for Novel Immunobiology Research
    paradigm shift in the science of chronic diseases and may lead to new prevention ... body's innate immune system activates inflammatory mechanisms that help to combat these ...
    4-9-2013
  • KannaLife in R&D Collaboration for Cannabinoid-Based Drugs
    receptor antagonism, making them useful in treating and protecting the body from a variety of oxidation-associated ischemic, age-related, inflammatory, and autoimmune diseases. ...
    4-4-2013
  • Pfizer, BIND Launch $210M+ Targeted Nanomedicine Collaboration
    Accurin technology has shown effectiveness in internal research, he said, against inflammatory diseases and cancer, where vascular irregularity and permeability allow particles to ...
    4-2-2013
  • Exploiting Folate Pathways to Treat Cancer
    to Its Therapies Endocyte is developing targeted small molecule drug conjugates, each with a companion imaging diagnostic, for the treatment of cancer and inflammatory diseases. ...
    4-1-2013
  • Hope for Autism Lies in Century-Old Drug
    for almost a century to treat other diseases to block the 'danger' signal in a mouse ... new class of anti-inflammatory drugs to treat autism and several other disorders," Dr. ...
    3-14-2013
  • Receptos Licenses AbbVie Antibody for Co-Development
    Receptos, a San Diego developer of drugs for immune and metabolic diseases, said it plans ... (GPCR) target for relapsing multiple sclerosis (RMS) and inflammatory bowel disease. ...
    3-13-2013
  • Personalized Medicine: Why We Are So Excited
    ... Similarly, diseases affecting specific organs such as various types of cancers, or certain systemic inflammatory diseases may be triggered by a single common molecular mechanism. ...
    3-8-2013
  • Small Firms Look Optimistically to Future
    ... conserved," said Peter DiLaura, CEO. "The link between the microbiome and disease is strongest in inflammatory and metabolic diseases, and in hospital-acquired infections." ...
    3-1-2013
  • Addressing Unmet Medical Needs with Complex Carbohydrate Chemistry
    have been shown to play a fundamental role in normal cell functions as well as in major disease pathologies including cancer, cardiovascular disease, and inflammatory diseases. ...
    2-28-2013
  • More »

    Journal Articles

  • Statins Could Be Used to Control Replication of Some Viruses...
    Caroline Gilbert, Marc Bergeron, Sylvie Méthot, Jean-François Giguère, Michel J. Tremblay
    Viral Immunology
    LFA-1 affinity by inhibiting prenylation of the small GTPases could prove useful to treat inflammatory, autoimmune diseases and possibly viral infections, including HIV-1.
  • Sialome Individuality Between Aedes aegypti Colonies
    L. Almeras, E. Orlandi-Pradines, A. Fontaine, C. Villard, E. Boucomont, L. Denis de Senneville, M. Baragatti, A. Pascual, B. Pradines, N. Corre-Catelin, F. Pages, P. Reiter, C. Rogier, T. Fusai
    Vector-Borne and Zoonotic Diseases
    Sialome Individuality Between Aedes aegypti Colonies Vector-Borne and Zoonotic Diseases ... biochemical activities; anti-hemostatic, angiogenic, inflammatory, and immunomodulatory. ...
  • Immunological Responses and the Pattern of Disease in Mice Infected...
    Marina Bersudsky, Avraham Laban, Joseph El-On
    Vector-Borne and Zoonotic Diseases
    Vector-Borne and Zoonotic Diseases Immunity against leishmaniasis is mediated mainly by ... The aim of this study was to induce the expression of the inflammatory cytokine IL-1a by ...
  • Experience with Two Cases of Intestinal Tuberculosis: Utility...
    Damiano Caputo, Rossana Alloni, Andrea Garberini, Giordano Dicuonzo, Silvia Angeletti, Giovanni Gherardi, Elisabetta Ferraro, Roberto Coppola
    Surgical Infections
    Conclusions: The QuantiFERON-TB Gold test may hold promise for use in intestinal inflammatory diseases when tuberculosis is suspected but conventional workup is not diagnostic.

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll